KNTC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.424800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.046000E-01
Normal-vs-Stage2
6.784200E-01
Normal-vs-Stage3
2.960600E-01
Normal-vs-Stage4
5.548600E-01
Stage1-vs-Stage2
3.003600E-01
Stage1-vs-Stage3
5.311400E-01
Stage1-vs-Stage4
5.527000E-01
Stage2-vs-Stage3
1.792430E-01
Stage2-vs-Stage4
7.860400E-01
Stage3-vs-Stage4
3.384200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.610000E-01
Normal-vs-AfricanAmerican
3.657000E-01
Normal-vs-Asian
5.298800E-01
Caucasian-vs-AfricanAmerican
4.722200E-01
Caucasian-vs-Asian
3.016800E-01
AfricanAmerican-vs-Asian
9.603600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.430000E-01
Normal-vs-Female
6.465000E-01
Male-vs-Female
9.657400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.478200E-01
Normal-vs-Age(41-60Yrs)
7.181000E-01
Normal-vs-Age(61-80Yrs)
6.145000E-01
Normal-vs-Age(81-100Yrs)
6.696000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.594770E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.776000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.389440E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.838790E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.329800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.015200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.736200E-01
Normal-vs-Daily Drinker
4.397200E-01
Normal-vs-Weekly Drinker
6.483200E-01
Normal-vs-Occasional Drinker
7.607200E-01
Normal-vs-Social Drinker
6.580200E-01
Non Drinker-vs-Daily Drinker
7.380200E-01
Non Drinker-vs-Weekly Drinker
9.607400E-01
Non Drinker-vs-Occasional Drinker
4.480200E-01
Non Drinker-vs-Social Drinker
8.650800E-01
Daily Drinker-vs-Weekly Drinker
7.994600E-01
Daily Drinker-vs-Occasional Drinker
6.601200E-01
Daily Drinker-vs-Social Drinker
8.290000E-01
Weekly Drinker-vs-Occasional Drinker
4.945200E-01
Weekly Drinker-vs-Social Drinker
9.235600E-01
Occasional Drinker-vs-Social Drinker
4.811000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.311800E-01
Normal-vs-Grade 2
8.637200E-01
Normal-vs-Grade 3
4.526200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.012030E-02
Grade 1-vs-Grade 3
1.803620E-03
Grade 1-vs-Grade 4
8.311800E-01
Grade 2-vs-Grade 3
7.389700E-02
Grade 2-vs-Grade 4
8.637200E-01
Grade 3-vs-Grade 4
4.526200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.782600E-01
Normal-vs-NonDiabetic
6.536400E-01
Diabetic-vs-NonDiabetic
3.406200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.623600E-01
Normal-vs-NoPancreatitis
6.199400E-01
Pancreatitis-vs-NoPancreatitis
3.109600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.244200E-01
Normal-vs-N1
6.616600E-01
N0-vs-N1
6.189000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.511200E-01
Normal-vs-TP53-NonMutant
5.546200E-01
TP53-Mutant-vs-TP53-NonMutant
1.96008999999719E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
